|AMR Diabetes Study Experience
|Center for Pharmaceutical Research
1010 Carondelet Drive
Kansas City, Missouri 64114
|John E. Ervin, MD
|Conducted over 28 diabetes studies, including diabetes type I, type II, DPN, diabetic device study, and diabetic ulcer studies. Staff experienced with oral, injected, and inhaled medications. Over 2,863 diabetic subjects in our research database.
|Central Kentucky Research Associates, Inc
3475 Richmond Road, 3rd Floor
Lexington, Kentucky 40509
|James L. Borders, MD
|Site has conducted 9 Type II Diabetes trials reaching 169% of cumulative contracted enrollment. Site has also conducted trials with other indications in Diabetic populations such as Erectile Dysfunction and Metabolic Syndrome. Site does have a Sub-Investigator Board certified in Endocrinology.
|Clinical Research Associates of Tidewater
400 Gresham Drive
402 Medical Tower
Norfolk, Virginia 23507
|Duane G. Wombolt, MD
|CRAT has conducted 15 diabetes studies and has over 950 diabetics in database. PI has over 30 years clinical research experience and is a Certified Principal Investigator by the ACRP. Clinical Research Coordinators are also certified by ACRP. Sub-I has a Fellowship in Endocrinology. We also work with an endocrinology group practice.
|Clinical Research Consortium
2110 E. Flamingo
Las Vegas, Nevada 89119
|V. Jerome Mirkil, MD
|Investigators and coordinators have successful experience with previous diabetes and diabetic neuropathy studies. Well suited for weight management studies with the following resources:
Extensive searchable database
Ability to pre-identify patients
Database includes >18,000 patients
Experienced board certified principal investigators
Ability to use central IRB
|Clinical Research Consortium Arizona
2727 W Baseline Rd
Tempe, Arizona 85283
|Enrique Cifuentes Jr, M.D.
|Well suited for diabetes studies with the following resources:
Experienced board certified principal investigators
|Clinical Research of South Florida
370 Minorca Avenue
Coral Gables, Florida 33134
|Jeffrey B. Rosen, M.D.
||Maria M. Rodriguez, RMA-CRT-CCRC
|CRSF has over 30 years experience in diabetic clinical research. We have conducted 71 trials in DMII and are consistently among the top enrollers. Studies have included diabetes with hypertension, with erectile dysfunction, with obesity and with hyperlipidemia. We have also conducted many studies in patients with impaired fasting glucose and/or metabolic syndrome. Dr. Rosen has presented at the 2009, 2010, and 2012 European Association for the Study of Diabetes Annual Meeting on Metabolic Syndrome and lipids.
CRSF has an extensive database of patients and is located adjacent to an affiliated large primary care practice. These two sources of patients enable rapid enrollment.
19-Diabetes-Phase III in adults
53-Diabetes-Phase II in adults
Inhaled Insulin-Phase II in adults
Diabetes-Phase II in hypertensive & O/A population
Diabetes-Phase II in elderly population
Diabetes-Phase II in PVD population
Diabetes-Phase II in hyperlipidemic population
Diabetes-Phase II in CAD population
Diabetes-Phase II in Sleep Apnea population
2-Diabetes-Phase II in ED population
3-Diabetes-Phase III in Insulin Dependent population
4-Diabetes-Phase II in Hypertensive population
4-Diabetes-Phase II in Obese population
|Coastal Clinical Research, Inc.
100 Memorial Hospital Drive
Annex Building, Suite 3B
Mobile, Alabama 36608
|Harry Studdard, MD
Board Certified Internist
|Lauren B. Garner
|Site has conducted:
Type II diabetes - 9 trials
Type I diabetes - 1 trial
* Three sub-investigators
* Research site database of 1,643 diabetes patients
|Heartland Medical, PC
309 N. Broad Street
New Tazewell, Tennessee 37825
|Charles H. DeBusk, MD
423-626-7297 x 2234
|19 years clinical research experience. Conducted over 100 clinical trials, with 13 of them being diabetic studies. Study staff consists of PI, two sub-investigators, two full-time study coordinators, and one full-time regulatory specialist with 15 years experience. Very large patient database (45,000-50,000) in rural area with excellent patient retention. Serve tri-state area of Tennessee, Virginia, and Kentucky.
|Heartland Research Associates, LLC
1709 South Rock Road
Wichita, Kansas 67207
|Thomas Klein, MD
Richard Egelhof, MD
Teran Naccarato, MD
Richard Glover, MD
|- Conducted over 100 Type II Diabetes trials
- Overall 95% enrollment success
- Combined clinic and research databases of over 10,500 diabetes potential subjects
- Experience with oral, device, injectable, and inhaled medications.
- Affiliation with Heartland Diabetes Associates, LLC
- Certified Diabetes Educators and Registered Dieticians
|Maine Research Associates
2 Great Falls Plaza
Auburn, Maine 04210
|Robert Weiss, MD
||Robert Weiss, MD
|Completed over 30 diabetic research studies.
|MediSphere Medical Research Center, LLC
1401 Professional Boulevard
Evansville, Indiana 47714
|Hubert S. Reyes, MD
Alexa Dela Llana, MD
Mike Sebastian, MD
Steven K. Elliott, MD
|20 years experience 4 Board-certified Investigators.
We have conducted over 80 Diabetes studies Phase II, III and IV more than 3,000 Diabetes patients in database 4 Study Coordinators (2 CCRC certified), 4 Patient Recruiters Regulatory Administrator
|Rochester Clinical Research
500 Helendale Road
Rochester, New York 14609
|Matthew Davis, MD
| 95 Type 2 DM trials
experienced with glucometer training
Full-time registered dietitian on staff, Certified Diabetes Educator,
Diabetes self-management group open to community and taught by site staff.
Site DB with 2700 DM patients ability to sort by BMI and concomitant meds, tracking a l c.
Free screening program open to community with Metrika and FBS tested.
|VRG/New Orleans Center for Clinical Research
1928 Alcoa Hwy
Knoxville, Tennessee 37920
|William B. Smith, MD, Knoxville, Tennessee /
Ramon Vargas, MD, New Orleans, Louisiana
|VRG/NOCCR have conducted 65 diabetes trials in Phase I-IV. We have certified diabetic educators and registered dieticians available and experience with oral, injectable and inhaled medications.
NOCCR and VRG are multispecialty research centers with over 30 years of experience and have conducted over Phase I IV trials. The benefits we offer sponsors include: two independent locations - one of which are located within an academic hospital, a 50 bed capacity Phase I unit, a state-of-the-art Mortara Surveyor System, added layers of safety (with code team and 24-hour critical care coverage), access to specialists and patient populations, on-site clinical electronic transfer lab for same day results, USP pharmacy capabilities, and on-site imaging services. Additionally, our hospital based units are the research arms for the 718 University physicians, which allow our primary Principal Investigators to collaborate with specialty PIs in all therapeutic areas.